Viewing Study NCT01325194


Ignite Creation Date: 2025-12-25 @ 1:40 AM
Ignite Modification Date: 2026-01-21 @ 9:46 PM
Study NCT ID: NCT01325194
Status: COMPLETED
Last Update Posted: 2020-03-03
First Post: 2011-03-14
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis
Sponsor: Nordic Lymphoma Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None DLBCL View
None FL grade 3B View
None high risk View
None CNS prophylaxis View
None chemoimmunotherapy View